At a glance
ClinicalIndex Comparison RecordN/ACompleted· 704 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Fetal Growth Restriction & Maternal Cardiovascular Risk
The University of Texas Health Science Center, Houston·observational·Posted Oct 19, 2005·Updated Jan 21, 2013
In Brief
An observational study for Cardiovascular Diseases and Heart Diseases. Completed, enrolled 704 participants.
Detailed Summary
To determine whether or not women with a history of having a baby with intrauterine growth retardation (IUGR) was more likely to have risk factors for cardiovascular disease versus women with a pregnancy not complicated by IUGR.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2005
First PostedOct 2005
Primary CompletionApr 2009
TodayJul 2026
First PostedOct 19, 2005
Enrollment StartAug 1, 2005
Primary CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 20.7 years ago